MADISON, Wis. — Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said.

Madison-based Exact Sciences is known for its cancer detection technology such as Cologuard. Abbott announced last year that it would buy the company for $23 billion.

“The addition of Exact Sciences enhances Abbott’s growth profile and strengthens our leadership in diagnostics,” Abbott chairman and CEO Robert Ford said in a statement on Friday. “This transaction brings a powerful new platform in cancer screening and diagnostics into Abbott, advancing our mission to make care more accessible and give people more control over their health.”

Abbott said Friday that it had received all regulatory clearances for the acquisition.

Originally founded in Massachusetts in 1995, Exact Sciences made the move to Madison in 2009.

​COPYRIGHT 2026 BY CHANNEL 3000. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.